Publications by authors named "Peter J Craig"

Claim this Profile
T
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
Thomas Blackmore, Soraya Meftah, Tracey Karen Murray, Peter James Craig, Anthony Blockeel

Alzheimers Res Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screening.
Peter J Craig, Suchira Bose, Ruud Zwart, Ruth E Beattie, Elizabeth A Folly

Eur J Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of arsenic on antimony methylation by the aerobic yeast Cryptococcus humicolus.
Louise M Hartmann, Peter J Craig, Richard O Jenkins

Arch Microbiol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties.
Non M Evans, Suchira Bose, Giovanni Benedetti, Ruud Zwart, Kathy H Pearson, Peter J Craig

Eur J Pharmacol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of methylantimony species by an aerobic prokaryote: Flavobacterium sp.
Richard O Jenkins, Sarah N Forster, Peter J Craig

Arch Microbiol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor.
Lisa M Broad, Catherine Felthouse, Ruud Zwart, Gordon I McPhie, Kathy H Pearson, Peter J Craig

Eur J Pharmacol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis